Pfizer Raises 2026 Financial Outlook and Appoints New CFO
Pfizer (PFE) has raised its full-year financial outlook following the reporting of third-quarter 2026 results that exceeded market expectations. Despite the upward revision, quarterly revenue remained relatively flat due to declining demand for COVID-19 related products. In a significant leadership transition, the company also announced the appointment of Cecile Guegan as its next Chief Financial Officer. The move comes as Pfizer continues to navigate the post-pandemic landscape and adjust its growth strategy.
Tickers: $PFE
Topics: earnings report executive appointment guidance hike
Read the full article at Seeking Alpha
Part of the story Premarket Stock Movements: Pfizer, Apple, Palantir, and Zebra Technologies Report Q3 Results (3 articles)